Cargando…
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function
INTRODUCTION: Lymphangioleiomyomatosis (LAM) is a rare low-grade metastasising disease characterised by cystic lung destruction. The genetic basis of LAM remains incompletely determined, and the disease cell-of-origin is uncertain. We analysed the possibility of a shared genetic basis between LAM an...
Autores principales: | Farré, Xavier, Espín, Roderic, Baiges, Alexandra, Blommaert, Eline, Kim, Wonji, Giannikou, Krinio, Herranz, Carmen, Román, Antonio, Sáez, Berta, Casanova, Álvaro, Ancochea, Julio, Valenzuela, Claudia, Ussetti, Piedad, Laporta, Rosalía, Rodríguez-Portal, José A., van Moorsel, Coline H.M., van der Vis, Joanne J., Quanjel, Marian J.R., Tena-Garitaonaindia, Mireia, Sánchez de Medina, Fermín, Mateo, Francesca, Molina-Molina, María, Won, Sungho, Kwiatkowski, David J., de Cid, Rafael, Pujana, Miquel Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784893/ https://www.ncbi.nlm.nih.gov/pubmed/35083324 http://dx.doi.org/10.1183/23120541.00375-2021 |
Ejemplares similares
-
Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis
por: Herranz, Carmen, et al.
Publicado: (2021) -
Study of breast cancer incidence in patients of lymphangioleiomyomatosis
por: Nuñez, Olivier, et al.
Publicado: (2016) -
Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2015) -
Correction: Lymphangioleiomyomatosis Biomarkers Linked to Lung Metastatic Potential and Cell Stemness
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2018) -
Chylothorax, in the Spotlight of Lymphangioleiomyomatosis
por: Gámez-Baeza, Pablo, et al.
Publicado: (2022)